Better Results Obtained by Daily Supplementation of Iron Drops in Toddlers with Iron Deficiency Anemia in Iran
Author(s):
Abstract:
Background
The "Iron Supplementation Project" for anemic toddlers in Iran has not been subject to scientific studies yet. Since daily consumption of iron drops by children could bring about physical and mental problems, the aim of this study was to determine whether weekly doses of iron drops would also improve the iron status of children significantly. Materials And Methods
We determined the iron status of 12 to 21-month-old anemic toddlers receiving iron drops (ferrous sulfate) daily referred to health care centers in Shiraz. One hundred and four children were divided into two groups; one group receiving iron drops (1 mg/kg) daily as before, and the other group receiving iron drops weekly (3 mg/kg). Results
After three months children showed a significant increase in hemoglobin (Hb), mean corpuscular hemoglobin (MCH), and mean cellular hemoglobin concentration (MCHC) levels. Although weekly supplementation led to a significant increase in Hb levels, daily supplementation had a significantly greater effect than weekly supplementation on the levels of mean corpuscular volume (MCV) and MCHC. Conclusion
We generally conclude that weekly iron supplementation is not suitable for anemic children.Language:
English
Published:
Iranian Journal of Blood and Cancer, Volume:1 Issue: 4, Summer 2009
Page:
159
https://www.magiran.com/p771033
مقالات دیگری از این نویسنده (گان)
-
MYCN Gene Copy Number Status Detected by FISH Method and Its Correlation with Outcome and Clinicopathological Variables in Childhood Neuroblastoma
*, Akbar Safaei, Parvaneh Davoudi, Bozorgmehr Hedayati
Middle East Journal of Cancer, Jan 2024 -
The protective role of deferoxamine in the prevention of doxorubicin-induced hepatic fibrosis in children: A randomized controlled clinical trial
Mohammadreza Bordbar, Gholamreza Fathpour*, Seyed Mohsen Dehghani, Sezaneh Haghpanah, Hossein Molavi Vardanjani, Mohammadreza Fattahi, , Nader Shakibazad
Iranian Journal of Blood and Cancer, Sep 2022